IAV-CNE

N/A

Report date: 2026/05/12 09:10:09

Base Information

Drug NameIAV-CNE

Drug Alias NameIAV-CNE

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsEncephalomyelitis, Venezuelan Equine

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc

Inactive CompaniesN/A

Active IndicationsEncephalomyelitis, Venezuelan Equine

Inactive IndicationsN/A

Other Information

ATC CodeN/A